Fundraising Fox
RCE Technologies
Carlsbad, US · Founded 2018 · 1 known investors
Find your way into RCE Technologies
Sign up to see every warm intro you have to RCE Technologies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RCE Technologies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
RCE Technologies develops a wrist-worn wearable (Infrasensor) that uses infrared sensors and machine learning to detect signals associated with severe coronary artery occlusion, aiming for earlier heart attack detection. The technology targets clinical and acute care settings such as emergency departments and pre-hospital paramedic use.
Founders & leadership
AB
ATANDRA BURMANFounder & CEOBefore starting RCE in 2018, Atandra Burman was a venture partner at NextGen Venture Partners and spent several years at Y Media Labs, where he rose from director to VP of product and program management. His earlier career was in software engineering, with roles at Overstock.com, Yahoo!, and Micron Technology.
LM
LOU MALICENamed on SEC filing
SB
Samir BatraNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$5.9M disclosed across 6 rounds · 2019–2026
▶$110KraisedOct 2026 · 2 investors · Other Health CareRule 506(b)
▶$110KraisedOct 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Atandra BurmanExecutive Officer, Director
- Lou MaliceDirector
- Samir BatraDirector
- Offering amount
- $3M
- Amount sold
- $110K
- Minimum investment
- $1
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$25KraisedDec 2025 · 3 investors · Other Health CareRule 506(b)
▶$25KraisedDec 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Atandra BurmanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $25K
- Minimum investment
- $5K
- Proceeds to insiders
- $100K
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedNov 2025 · 37 investors · BiotechnologyRule 506(b)
▶$2.1MraisedNov 2025 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ATANDRA BURMANExecutive Officer, Director
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedDec 2023 · 43 investors · BiotechnologyRule 506(b)
▶$1.7MraisedDec 2023 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LOU MALICEDirector
- ATANDRA BURMANExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.7M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedJan 2022 · 14 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJan 2022 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ATANDRA BURMANExecutive Officer, Director
- LOU MALICEDirector
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$610KraisedJun 2021 · 23 investors · BiotechnologyRule 506(b)
▶$610KraisedJun 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ATANDRA BURMANExecutive Officer, Director
- LOU MALICEDirector
- Offering amount
- $2M
- Amount sold
- $610K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2023 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does RCE Technologies do?
- RCE Technologies develops a wrist-worn wearable (Infrasensor) that uses infrared sensors and machine learning to detect signals associated with severe coronary artery occlusion, aiming for earlier heart attack detection. The technology targets clinical and acute care settings such as emergency departments and pre-hospital paramedic use.
- Who are RCE Technologies's investors?
- RCE Technologies's investors include Atlanta Technology Angels.
- How much funding has RCE Technologies raised?
- RCE Technologies has disclosed $5.9M raised across 6 rounds.
- Where is RCE Technologies headquartered?
- RCE Technologies is headquartered in Carlsbad, US.